Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
2.
Recenti Prog Med ; 104(4): 168-76, 2013 Apr.
Article in Italian | MEDLINE | ID: mdl-23748641

ABSTRACT

Surgery is an almost inevitable event in Crohn's disease but is not curative; post-operative recurrence follows a sequential and predictable course. Prevention of post-operative recurrence in Crohn's disease is therefore a relevant problem in the management of the disease. Several drugs have been evaluated to decrease the risk of recurrence: these include mesalazine, antibiotics, probiotics, budesonide, thiopurines and biologic agents. This review focuses on the randomised controlled trials and meta-analyses addressing different drugs and strategies for preventing post-operative recurrence in Crohn's disease.


Subject(s)
Crohn Disease/prevention & control , Meta-Analysis as Topic , Randomized Controlled Trials as Topic/statistics & numerical data , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Antibodies, Monoclonal/therapeutic use , Antirheumatic Agents/therapeutic use , Budesonide/therapeutic use , Combined Modality Therapy , Crohn Disease/drug therapy , Crohn Disease/surgery , Drug Therapy, Combination , Endoscopy, Digestive System , Humans , Immunosuppressive Agents/therapeutic use , Infliximab , Interleukin-10/therapeutic use , Lactobacillus , Mesalamine/therapeutic use , Multicenter Studies as Topic , Probiotics/therapeutic use , Secondary Prevention , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...